We’re experimenting with AI-generated content to help deliver information faster and more efficiently.
While we try to keep things accurate, this content is part of an ongoing experiment and may not always be reliable.
Please double-check important details — we’re not responsible for how the information is used.

Disability

“Lunar Trailblazer: A Small Satellite’s Quest to Map Water on the Moon Falls Short”

NASA’s Lunar Trailblazer, a mission designed to create high-resolution maps of water on the Moon, ended after losing contact with the spacecraft just one day after its February 26 launch. Despite extensive global efforts to reestablish communication, the small satellite’s misaligned solar arrays prevented its batteries from charging, leaving it powerless and drifting in a slow spin into deep space.

Published

1 day ago

August 12, 2025

Veronic D.

The Lunar Trailblazer, a small satellite designed to map water on the Moon’s surface, ended its mission in July 2023. Despite extensive efforts by its operators, they were unable to establish two-way communications with the spacecraft after losing contact just one day after launch.

Lunar Trailblazer was launched on February 26 aboard a SpaceX Falcon 9 rocket from Kennedy Space Center in Florida. It shared a ride on the second Intuitive Machines robotic lunar lander mission, IM-2. The small satellite separated as planned from the rocket about 48 minutes after launch to begin its flight to the Moon.

Mission operators at Caltech’s IPAC established communications with the small spacecraft at 8:13 p.m. EST. Contact was lost the next day. Without two-way communications, the team was unable to fully diagnose the spacecraft or perform the thruster operations needed to keep Lunar Trailblazer on its flight path.

“At NASA, we undertake high-risk, high-reward missions like Lunar Trailblazer to find revolutionary ways of doing new science,” said Nicky Fox, associate administrator, Science Mission Directorate at NASA Headquarters in Washington. “While it was not the outcome we had hoped for, mission experiences like Lunar Trailblazer help us to learn and reduce the risk for future, low-cost small satellites to do innovative science as we prepare for a sustained human presence on the Moon.”

The limited data the mission team had received from Lunar Trailblazer indicated that the spacecraft’s solar arrays were not properly oriented toward the Sun, which caused its batteries to become depleted. For several months, collaborating organizations around the world listened for the spacecraft’s radio signal and tracked its position.

Ground radar and optical observations indicated that Lunar Trailblazer was in a slow spin as it headed farther into deep space. “As Lunar Trailblazer drifted far beyond the Moon, our models showed that the solar panels might receive more sunlight, perhaps charging the spacecraft’s batteries to a point it could turn on its radio,” said Andrew Klesh, Lunar Trailblazer’s project systems engineer at NASA’s Jet Propulsion Laboratory in Southern California.

However, as time passed, Lunar Trailblazer became too distant to recover. Its telecommunications signals would have been too weak for the mission to receive telemetry and to command. Despite this setback, the technology developed for the mission will live on in future projects.

The High-resolution Volatiles and Minerals Moon Mapper (HVM3) imaging spectrometer was built by JPL to detect and map the locations of water and minerals. The Lunar Thermal Mapper (LTM) instrument was built by the University of Oxford in the United Kingdom and funded by the UK Space Agency to gather temperature data and determine the composition of silicate rocks and soils.

The collective knowledge and technology developed for Lunar Trailblazer will cross-pollinate to other projects as the planetary science community continues work to better understand the Moon’s water. Some of that technology will live on in the JPL-built Ultra Compact Imaging Spectrometer for the Moon (UCIS-Moon) instrument that NASA recently selected for a future orbital flight opportunity.

Lunar Trailblazer was selected by NASA’s SIMPLEx (Small Innovative Missions for Planetary Exploration) competition, which provides opportunities for low-cost science spacecraft to ride-share with selected primary missions. To maintain the lower overall cost, SIMPLEx missions have a higher risk posture and less-stringent requirements for oversight and management.

This higher risk acceptance bolsters NASA’s portfolio of targeted science missions designed to test pioneering mission approaches. Caltech, which manages JPL for NASA, led Lunar Trailblazer’s science investigation, and Caltech’s IPAC led mission operations.

Along with managing Lunar Trailblazer, NASA JPL provided system engineering, mission assurance, the HVM3 instrument, and mission design and navigation. Lockheed Martin Space provided the spacecraft, integrated the flight system, and supported operations under contract with Caltech. The University of Oxford developed and provided the LTM instrument, funded by the UK Space Agency.

Lunar Trailblazer, a project of NASA’s Lunar Discovery and Exploration Program, was managed by NASA’s Planetary Missions Program Office at Marshall Space Flight Center in Huntsville, Alabama, for the agency’s Science Mission Directorate in Washington.

Source:Jet Propulsion Laboratory

Original Link:https://www.sciencedaily.com/releases/2025/08/250811094005.htm

Up Next

Scientists Unlock Secret to Reversing Memory Loss by Boosting Brain’s Energy Engines

Don't Miss

Hubble Captures a Dazzling Star-Birthing Storm 160,000 Light-Years Away

Alzheimer's

Scientists Unlock Secret to Reversing Memory Loss by Boosting Brain’s Energy Engines

Scientists have discovered a direct cause-and-effect link between faulty mitochondria and the memory loss seen in neurodegenerative diseases. By creating a novel tool to boost mitochondrial activity in mouse models, researchers restored memory performance, suggesting mitochondria could be a powerful new target for treatments. The findings not only shed light on the early drivers of brain cell degeneration but also open possibilities for slowing or even preventing diseases like Alzheimer’s.

Published

13 hours ago

August 13, 2025

Veronic D.

Scientists have made a groundbreaking discovery that could potentially reverse memory loss associated with neurodegenerative diseases. Researchers from Inserm and the University of Bordeaux, in collaboration with colleagues from the Université de Moncton in Canada, have successfully established a causal link between mitochondrial dysfunction and cognitive symptoms related to these conditions.

Mitochondria are tiny energy-producing structures within cells that provide the power needed for proper functioning. The brain is one of the most energy-demanding organs, relying on mitochondria to produce energy for neurons to communicate with each other. When mitochondrial activity is impaired, neurons fail to function correctly, leading to progressive neuronal degeneration and eventually, cell death.

In Alzheimer’s disease, for example, it has been observed that impaired mitochondrial activity precedes neuronal degeneration and ultimately, leads to memory loss. However, due to the lack of suitable tools, researchers were unable to determine whether mitochondrial alterations played a causal role in these conditions or were simply a consequence of the pathophysiological process.

In this pioneering study, researchers developed a unique tool that temporarily stimulates mitochondrial activity. By activating G proteins directly in mitochondria using an artificial receptor called mitoDreadd-Gs, they successfully restored both mitochondrial activity and memory performance in dementia mouse models.

“This work is the first to establish a cause-and-effect link between mitochondrial dysfunction and symptoms related to neurodegenerative diseases,” explains Giovanni Marsicano, Inserm research director. “Impaired mitochondrial activity could be at the origin of the onset of neuronal degeneration.”

The tool developed by researchers has opened doors to considering mitochondria as a new therapeutic target for treating memory loss associated with neurodegenerative diseases. Further studies are needed to measure the effects of continuous stimulation of mitochondrial activity and determine its potential impact on symptoms and neuronal loss.

Ultimately, this research holds promise for identifying molecular and cellular mechanisms responsible for dementia, facilitating the development of effective therapeutic targets, and potentially delaying or even preventing memory loss associated with neurodegenerative diseases.

Alternative Medicine

A Sweet Breakthrough: How a Sugar Molecule Could Help Treat Type 1 Diabetes

In a fascinating twist, Mayo Clinic researchers discovered that a sugar molecule cancer cells use to hide from the immune system might also protect insulin-producing beta cells in type 1 diabetes. By engineering these cells with the same sugar molecule—sialic acid—they prevented immune attacks in lab models. This approach could lead to better transplant options without broad immune suppression, offering hope for millions living with the autoimmune disease.

Published

1 week ago

August 3, 2025

Veronic D.

In a groundbreaking study, researchers at Mayo Clinic have discovered that a sugar molecule used by cancer cells to evade the immune system could also help treat type 1 diabetes. The team, led by immunology researcher Virginia Shapiro, Ph.D., found that dressing up beta cells with the same sugar molecule, known as sialic acid, enabled the immune system to tolerate them.

Type 1 diabetes is a chronic autoimmune condition in which the immune system mistakenly attacks pancreatic beta cells that produce insulin. This leads to an estimated 1.3 million people in the U.S. suffering from the disease. In their studies, Shapiro’s team used a cancer mechanism and turned it on its head by applying it to type 1 diabetes.

The researchers took a closer look at a preclinical model of type 1 diabetes and found that beta cells engineered to produce an enzyme called ST8Sia6, which increases sialic acid on the surface of tumor cells, were not attacked by the immune system. In fact, they were 90% effective in preventing the development of type 1 diabetes.

The team’s findings show that it is possible to engineer beta cells that do not prompt an immune response. This breakthrough has the potential to improve therapy for patients with type 1 diabetes, who currently rely on synthetic insulin or transplantation of pancreatic islet cells with immunosuppression.

Dr. Shapiro aims to explore using the engineered beta cells in transplantable islet cells without the need for immunosuppression. While still in the early stages, this study may be one step toward improving care for patients with type 1 diabetes.

Disability

The Silent Threat: How Hearing Loss and Loneliness Fuel Memory Decline

A massive European study has uncovered a powerful connection between hearing loss, loneliness, and memory decline. Researchers at the University of Geneva found that older adults with hearing impairments who also feel lonely—regardless of actual social isolation—experience faster cognitive decline.

Published

4 weeks ago

July 18, 2025

Veronic D.

The silent threat of hearing loss and loneliness is fueling memory decline, particularly among older adults. Researchers at the University of Geneva have analyzed data from 33,000 people across Europe and identified three distinct profiles related to social isolation and perceived loneliness. The findings show that hearing loss accelerates cognitive decline, especially among individuals who feel lonely, regardless of whether they are socially isolated.

The World Health Organization (WHO) predicts that nearly 2.5 billion people will experience hearing loss or impairment by 2050. More than 25% of people over the age of 60 experience disabling hearing impairment, which is linked to a significantly increased risk of cognitive decline in later life. This risk may be two to three times higher for those affected.

The study used data from the SHARE survey (Survey of Health, Ageing and Retirement in Europe), which examines the health and aging of Europeans aged 50 and over. The researchers identified three distinct profiles related to social isolation and perceived loneliness:

1. Isolation: This profile refers to individuals who are socially isolated, meaning they have few or no social connections.
2. Loneliness: This profile refers to individuals who feel lonely, but may not be socially isolated. They may have social connections, but still feel disconnected from others.
3. Deafness and isolation: This profile refers to individuals who experience both hearing loss and social isolation.

The study found that people in the “deafness and isolation” profile had the most accelerated cognitive decline, while those in the “loneliness” profile also experienced significant declines. However, it’s essential to note that the “loneliness” profile was not necessarily linked to social isolation, but rather a subjective feeling of being disconnected from others.

The researchers emphasize the importance of addressing both hearing loss and the social and emotional dimensions of individuals in efforts to prevent cognitive decline. This is particularly crucial for people who are not socially isolated but still feel lonely, as simple hearing interventions may be enough to help them engage more fully in social life and protect their cognitive health.

In conclusion, the silent threat of hearing loss and loneliness is fueling memory decline, especially among older adults. It’s essential to address both aspects to prevent cognitive decline and ensure a healthy and happy aging process.